Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (A57891) - R9 - Effective February 10, 2020

Date Posted: November 20, 2025

This Billing and Coding Article has been revised under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).

Effective Date: February 10, 2020

Summary of Changes:

Under ICD-10 Codes that Support Medical Necessity Group 1: Codes added C94.20, C94.22, and D75.839. This revision is effective 2/10/2020.

Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCDs or access it via the CMS MCD.

Last Updated Nov 19 , 2025